Regeneron Pharmaceuticals
Tarrytown, NY, United StatesFounded 1988Industry
Regeneron makes Inmazeb (REGN-EB3), an FDA-approved Ebola antibody treatment that BARDA has supported through development and procurement for national preparedness stockpiles.
What it does
Threats covered
Categories
Profile
Regeneron Pharmaceuticals is a Nasdaq-listed biotechnology company headquartered in Tarrytown, New York. Inmazeb is its FDA-approved three-antibody treatment for Orthoebolavirus zairense, developed with BARDA and Department of Health and Human Services support under contracts HHSO100201700016C and HHSO100201500013C.
More profile
A related BARDA contract, HHSO100201700020C, had a performance period through 31 May 2026, according to a Freedom of Information release. In 2025 Regeneron donated up to 500 Inmazeb doses to the World Health Organization for use in low and lower-middle-income countries.
Its annual report for 2025 and first quarter 2026 report are on the SEC register. Ebola treatment is a small part of a very large commercial biotechnology business.
Contract values were not read.
Ownership
Publicly listed on Nasdaq (REGN)
Parent: none (publicly listed) (checked)
Sources (5)
- https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-donates-ebola-treatment-use-countries-most-risk/
- https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm
- https://www.keionline.org/misc-docs/FOIA/HHS-BARDA-Regeneron-Contract-HHSO100201700020C-Mod0008-15June2020.pdf
- https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/regn-20260331.htm
- https://investor.regeneron.com/news-releases/news-release-details/barda-procures-regenerons-regn-eb3-investigational-ebola/
Not verified or not found
- Founding year 1988: not stated in these sources.
- Contract values: not read.
Questions
What does Regeneron Pharmaceuticals do?
Regeneron makes Inmazeb (REGN-EB3), an FDA-approved Ebola antibody treatment that BARDA has supported through development and procurement for national preparedness stockpiles.
Where is Regeneron Pharmaceuticals based?
HQ (as found): Tarrytown, NY. HQ country: US.
Who owns Regeneron Pharmaceuticals?
Publicly listed on Nasdaq (REGN). Parent: none (publicly listed) (checked)
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction